These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6358180)

  • 21. Effect of N-acetyl-muramyl-L-alanyl-D-isoglutamine on interferon production in mice by Newcastle disease virus.
    Sakuma T; Azuma M; Yoshida I
    J Gen Virol; 1984 May; 65 ( Pt 5)():999-1003. PubMed ID: 6202835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
    McCoy DM; Brown GL; Ausobsky JR; Polk HC
    Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of intradiscal antibiotics for discography: an in vitro study of gentamicin, cefazolin, and clindamycin.
    Klessig HT; Showsh SA; Sekorski A
    Spine (Phila Pa 1976); 2003 Aug; 28(15):1735-8. PubMed ID: 12897501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
    Dinarello CA; Elin RJ; Chedid L; Wolff SM
    J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of reticuloendothelial function by muramyl dipeptide-encapsulated liposomes in jaundiced rats treated with biliary decompression.
    Ding JW; Andersson R; Hultberg B; Soltesz V; Bengmark S
    Scand J Gastroenterol; 1993 Jan; 28(1):53-62. PubMed ID: 8430273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I; Fidler IJ
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiproliferative activity of conjugates of adenosine with muramyl dipeptide and nor-muramyl dipeptide derivatives.
    Samsel M; Dzierzbicka K; Trzonkowski P
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3587-91. PubMed ID: 24915876
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
    World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergism between muramyl dipeptide and lipopolysaccharide in the inhibition of glycosaminoglycan synthesis in cultured rat costal chondrocytes.
    Ikebe T; Hirata M; Yanaga F; Koga T
    Ann Rheum Dis; 1993 Jan; 52(1):32-6. PubMed ID: 8427511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of tumor necrosis factor in nude mice by muramyl peptides associated with bacterial vaccines.
    Noso Y; Parant M; Parant F; Chedid L
    Cancer Res; 1988 Oct; 48(20):5766-9. PubMed ID: 3167834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulating effect of subinhibitory concentrations of compound LY 127935 on the virulence of Escherichia coli in the mouse.
    Pusztai-Markos Z; Pranada F; Leimbrock C
    Chemotherapy; 1982; 28(2):135-42. PubMed ID: 6210490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplicity of biological effects of muramyl dipeptide.
    Masek K
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):97-9. PubMed ID: 3713377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway.
    Kapoor A; Fan YH; Arav-Boger R
    Sci Rep; 2016 Feb; 6():20295. PubMed ID: 26830977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dialkylmethyl beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine: synthesis and infection protective and cytotoxic activities].
    Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kuzovlev FN; Kaliuzhin OV; Kiselevskií MV
    Bioorg Khim; 2008; 34(1):114-20. PubMed ID: 18365746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity.
    Leclerc C; Bourgeois E; Chedid L
    Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increase of non-specific resistance to infection by synthetic adjuvants].
    Parant M; Chedid L
    C R Seances Soc Biol Fil; 1979; 173(2):201-12. PubMed ID: 159749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological study of local skin injected with adjuvant-active and -inactive muramyl dipeptide (MDP) (histological change in MDP injected skin.
    Okuyama H; Kobayashi S; Azuma I
    Asian Pac J Allergy Immunol; 1983 Dec; 1(2):89-96. PubMed ID: 6681013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.